Richard Morgan Powell (Richard Powell, Richard M Powell)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Immune Response

Binding Protein

Top Venues

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Hayden Pearce, Wayne Croft, Samantha M Nicol, Sandra Margielewska-Davies, Richard Morgan Powell, Richard J Cornall, Simon J Davis, Francesca Marcon, Matthew Richard Pugh, Eanna Fennell, Sarah F Powell-Brett, Brinder S Mahon, Rachel M Brown, Gary M Middleton, Keith J Roberts, Paul A H Moss
Tissue-resident memory T cells in pancreatic ductal adenocarcinoma co-express PD-1 and TIGIT and functional inhibition is reversible by dual antibody blockade. Cancer immunology research (2023)
Hayden Pearce, Wayne Croft, Samantha M Nicol, Sandra Margielewska-Davies, Richard Morgan Powell, Richard J Cornall, Simon J Davis, Francesca Marcon, Matthew Richard Pugh, Eanna Fennell, Sarah F Powell-Brett, Brinder S Mahon, Rachel M Brown, Gary M Middleton, Keith J Roberts, Paul A H Moss
Tissue-resident memory T cells in pancreatic ductal adenocarcinoma co-express PD-1 and TIGIT and functional inhibition is reversible by dual antibody blockade. Cancer immunology research (2023)
Hayden Pearce, Wayne Croft, Samantha M Nicol, Sandra Margielewska-Davies, Richard Morgan Powell, Richard J Cornall, Simon J Davis, Francesca Marcon, Matthew Richard Pugh, Eanna Fennell, Sarah F Powell-Brett, Brinder S Mahon, Rachel M Brown, Gary M Middleton, Keith J Roberts, Paul A H Moss
Tissue-resident memory T cells in pancreatic ductal adenocarcinoma co-express PD-1 and TIGIT and functional inhibition is reversible by dual antibody blockade. Cancer immunology research (2023)
Pia Aehnlich, Richard Morgan Powell, Marlies J W Peeters, Anne Rahbech, Per Thor Straten
TAM Receptor Inhibition-Implications for Cancer and the Immune System. Cancers 13 (6) (2021)
Richard Morgan Powell, Marlies J W Peeters, Anne Rahbech, Pia Aehnlich, Tina Seremet, Per Thor Straten
Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8+ T Cells. Vaccines 9 (11) (2021)